We found that the mechanism between SFN and CDK2 in subnetwork 16 was supported by observations that SFN is a frequently hypermethylated gene41,42 emerging as a new inhibitor of CDK2 in breast cancer cells43. This evidence concerns the gene CDK2 and breast carcinoma.